US Market Overview for Cardiac Rhythm Management 2016 - MedView

US Market Overview for Cardiac Rhythm Management 2016 - MedView

  • January 2015 •
  • 35 pages •
  • Report ID: 3911594 •
  • Format: PDF
This report on cardiac rhythm management (CRM) devices analyzes the U.S. market for medical devices used for treating cardiac arrhythmias. The medical device markets included in this report are: implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads and wearable defibrillators.Heart failure affects over five million people annually in the U.S., and is the most costly cardiovascular illness with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices such as pacemakers, ICDs and CRT devices are implanted in patients with arrhythmias to correct cardiac pacing and/or to restart the heart after a sudden cardiac event. Sudden cardiac arrest (SCA) is one of the leading causes of death in the U.S., and is responsible for over 300,000 deaths annually. The chance of survival increases if defibrillation is delivered to the patient within ten minutes of the SCA event. This report on cardiac rhythm management (CRM) devices analyzes the U.S. market for medical devices used for treating cardiac arrhythmias. The medical device markets included in this report are: implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads and wearable defibrillators.